Entyvio and Lactose intolerance - a phase IV clinical study of FDA data

Summary:

We study 20,853 people who have side effects when taking Entyvio. Lactose intolerance is found, especially among people who are female, 30-39 old.

The phase IV clinical study analyzes which people take Entyvio and have Lactose intolerance. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

What are phase IV trials?

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 15, 2023

20,853 people reported to have side effects when taking Entyvio.
Among them, 2 people (0.01%) have Lactose intolerance.

What is Entyvio?

Entyvio has active ingredients of vedolizumab. It is used in crohn's disease. Currently, eHealthMe is studying from 20,977 Entyvio users.

What is Lactose intolerance?

Lactose intolerance (inability to digest lactose) is found to be associated with 1,257 drugs and 1,009 conditions by eHealthMe. Currently, we are studying 3,728 people who have Lactose intolerance.

Number of Entyvio and Lactose intolerance reports submitted per year:

Could Entyvio cause Lactose intolerance?

Gender of people who have Lactose intolerance when taking Entyvio *:

female: 100 %
male: 0.0 %

Age of people who have Lactose intolerance when taking Entyvio *:

Common side effects people have besides Lactose intolerance *:

Fatigue (feeling of tiredness): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Entyvio and have Lactose intolerance?

Check whether Lactose intolerance is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Lactose intolerance and when was it recovered:

Lactose intolerance in Entyvio

Expand to all the drugs that have ingredients of vedolizumab:

Lactose intolerance and drugs with ingredients of vedolizumab

Alternative drugs to, pros and cons of Entyvio:

Entyvio (20,977 reports)

Browse all side effects of Entyvio:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Lactose intolerance treatments and more:

Lactose intolerance (3,728 reports)

Common drugs associated with Lactose intolerance:

All the drugs that are associated with Lactose intolerance:

Lactose intolerance (1,257 drugs)

Common conditions associated with Lactose intolerance:

Multiple myeloma: 315 reports
High blood pressure: 220 reports
Pain: 118 reports
Osteoporosis: 114 reports
Rheumatoid arthritis: 109 reports

All the conditions that are associated with Lactose intolerance:

Lactose intolerance (1,009 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on vedolizumab (the active ingredients of Entyvio) and Entyvio (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.